JAK inhibitors
The first JAK inhibitor, Xeljanz (Tofacitinib), was approved for use by the FDA for rheumatoid arthritis use in 2012. It was a breakthrough medication for RA as it was the first to offer a targeted drug in pill form
Year: 2022
Cancer patients are brave.
I wrote this in 2014 about having cancer. My rheumatologist was responsible for finding my three cancers.
Polymyalgia rheumatica
Polymyalgia rheumatica is a disease of the elderly that can cause great difficulty in managing day to day activities. Shoulders and pelvic girdle.
RA symptoms, pain and Actemra
The reality is that the biologics do not relieve the RA symptoms for most of us. You only have to read the drug inserts to understand why.
Why the Shingles Vaccine?
With Shingrix you will less likely have Shingles and less likely have neuro complications caused by the varicella zoster virus.
Rheumatology Appointment and Garden update
When I visit my rheumatologist, I am armed with a list. Our time is short and there seems to be a lifetime between visits although it is only three months.
Shoulder Rheumatoid Arthritis
RA in the shoulder is painful and incapacitating. The shoulder has two joints. RA in the glenohumeral joint is disabling.
And the answer is Actemra
When my biologic stopped working, what was next? Orencia is the safest of the biologics, but only works about ten months for me. There is Actemra.
Spondyloarthritis
Spondyloarthritis is a group of similar diseases that affect the spine and other joints in the body. There is a juvenile version that has all the similarities of the adult varieties.
Springtime in Albuquerque
Life is good in Albuquerque with Francis. A decision will have to be made in the next few months about Imuran.
marysarthritis.com 